In the current health care landscape, never has there been so much risk or opportunity to develop and commercialize new therapeutics. In this forum, we will share different perspectives on nontraditional pharma partnerships that are designed to reduce risk and enhance innovation, including a CRO perspective to talk about ways to manage operational risk, a third-party capital perspective on managing financing risk, and a payer perspective on how pharma can manage commercial risk by partnering earlier on reimbursement strategy.

Learning Objectives:
Discuss key industry challenges and stakeholder views on potential solutions
Describe case studies for best practices, and lessons learned from conducting nontraditional partnerships.